Catalyst Wire Dossier Catalyst Wire Dossier

DIFLUNISAL

Diflunisal · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for DIFLUNISAL, covering 2006-12-14 to 2024-11-21. Get the full timeline:

Most recent: FDA Approved: DIFLUNISAL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing